Tesamorelin 10mg

What is Tesamorelin?

Tesamorelin is a synthetic analog of endogenous growth hormone-releasing hormone (GHRH), consisting of the full 44-amino-acid GHRH sequence with a trans-3-hexenoic acid modification for enhanced stability. It stimulates the pituitary gland to secrete growth hormone and has been researched extensively in models of GH deficiency and visceral adiposity.

Tesamorelin Structure

Tesamorelin Research

1. Tesamorelin and Visceral Fat Reduction

Clinical research has demonstrated significant reductions in visceral adipose tissue (VAT) with Tesamorelin administration, making it a key compound in metabolic and lipodystrophy research.

2. Tesamorelin and IGF-1 Levels

Studies consistently show Tesamorelin elevates IGF-1 levels in a GH-dependent manner, providing a measurable biomarker for its activity in research protocols.

3. Tesamorelin and Cognitive Research

Emerging data from aging population studies suggests Tesamorelin may influence cognitive function, potentially via GH/IGF-1 axis effects on hippocampal volume and function.

Future Tesamorelin Research

Future investigations are focused on NAFLD/NASH models, cognitive aging, and combined peptide protocols with GHRPs.

Tesamorelin Resources

• Falutz J, et al. – Metabolic effects of a growth hormone-releasing factor in patients with HIV. NEJM, 2007.
• Stanley TL, et al. – Effects of tesamorelin on non-alcoholic fatty liver disease. Lancet HIV, 2019.